We identify a population of multipotent CDX2; cells from term human placentas with clonal expansion, migratory capacity, and immune-privileged transcriptional profiles. Isolated from 180 healthy pregnancies, these cells differentiate into cardiomyocyte and vascular lineages in vitro and in vivo. Single-cell RNA sequencing uncovers distinct cardiogenic and vasculogenic subpopulations, along with immune-modulatory and chemotactic programs, providing a blueprint for precision-guided cardiovascular cell therapy. In a NOD/SCID myocardial infarction model, CDX2; cells restore cardiac function, and clonal propagation preserves their cardiovascular differentiation potential. These findings position placental CDX2; cells as an ethically accessible, regenerative platform for targeted treatment of cardiovascular disease.